von Willebrand Disease Presentation - Virginia Commonwealth ...

More documents

Recommendations

Info

Treatment of Epistaxis (Nosebleeds) • Treat wih Amicar and/or Stimate if orders to do so • Local measures: pressure, ice • Nosebleed QR powder (OTC) • If bleeding not stopped after 15 to 30 minutes, especially with bilateral heavy bleeding, needs medical attention • Local prevention (humidity, saline gel, neosynepherine)
Hormonal Therapy for vWD • Treatment with estrogen increases vWF levels in type 1 vWD • Birth control pills can be useful in treating heavy menstrual periods • A le<strong>von</strong>orgestrel intrauterine device. This is a contraceptive device that contains progestin. It’s placed in the uterus – opposing estrogen induced growth of the endometrium or lining of the uterus. • Endometrial ablation for women beyond childbearing or not interested in childbearing • Not effective treatment for type 2 vWD as structural defect will not be corrected Ewenstein BM. Annu Rev Med. 1997;48:525-542.
Page 1 and 2: Von Willebrand Disease: When is a
Page 3 and 4: Objectives • To review the clinic
Page 5 and 6: von Willebrand Disease (vWD) A pers
Page 7 and 8: Clotting Illustration William J. A
Page 9: Platelet Plug Formation • Platele
Page 12 and 13: Prevalence of vWD • Most common i
Page 14 and 15: Type 1 vWD • Most common type; in
Page 16: • Rare Type 3 vWD • Quantitativ
Page 19 and 20: vWD: Sites of Bleeding Mucous membr
Page 21 and 22: Symptoms of vWD • Bleeding after
Page 23 and 24: Characteristics of Menorrhagia •
Page 27 and 28: Causes of variance in Von Willebran
Page 29 and 30: Inheritance of vWD • Gene is carr
Page 31 and 32: Inheritance Pattern by Type of von
Page 33 and 34: Diagnosis of vWD • Personal and f
Page 35 and 36: Suggested Questions for Screening P
Page 37 and 38: Suggested Questions for Screening P
Page 39 and 40: Treatment of vWD • Treatment deci
Page 41 and 42: Intranasal Desmopressin: Stimate
Page 43 and 44: Side-effects of Stimate • Fluid r
Page 45: Amicar (aminocaproic acid) • Oral
Page 49 and 50: Treatment With vWF Concentrates (co
Page 51 and 52: Psychosocial Issues: Adolescent Wom
Page 53 and 54: Recommendations for Patients • Ha
Page 55 and 56: Summary • In VWD, you either have
Page 57 and 58: Summary • Treatments for VWD incl
Page 59 and 60: Referral for evaluation of VWD •
Page 61 and 62: Role of Hemophilia Treatment Center
Page 63: Virginia Bleeding Disorders Program

von Willebrand Disease Presentation - Virginia Commonwealth ...

Create successful ePaper yourself

Delete template?

Save as template?